Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Agenus - Stock Price History | AGEN

Historical daily share price chart and data for Agenus since 2020 adjusted for splits. The latest closing stock price for Agenus as of November 20, 2020 is 3.65.
  • The all-time high Agenus stock closing price was 315.72 on March 09, 2000.
  • The Agenus 52-week high stock price is 5.63, which is 54.2% above the current share price.
  • The Agenus 52-week low stock price is 1.82, which is 50.1% below the current share price.
  • The average Agenus stock price for the last 52 weeks is 3.55.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Agenus Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 3.0215 2.5100 4.4000 2.1700 4.0700 71.01%
2018 3.0122 3.5400 6.0400 1.5900 2.3800 -26.99%
2017 3.9090 4.1600 5.3700 3.2400 3.2600 -20.87%
2016 4.5745 4.4600 7.3600 2.7200 4.1200 -9.25%
2015 6.1392 3.9800 9.7800 3.8800 4.5400 14.36%
2014 3.2013 2.7800 5.1000 2.4100 3.9700 50.38%
2013 3.6174 4.2400 4.9300 2.4000 2.6400 -35.61%
2012 4.6131 2.1700 7.0400 2.1000 4.1000 105.00%
2011 4.3567 6.3587 6.6587 2.0000 2.0000 -66.99%
2010 5.3949 3.8548 8.2783 3.5999 6.0588 57.81%
2009 7.1490 2.8794 17.9364 1.7996 3.8392 33.33%
2008 10.4890 12.4775 18.1764 2.4595 2.8794 -76.47%
2007 14.9737 11.5177 26.5747 9.4181 12.2376 11.48%
2006 16.6463 28.7343 41.4517 9.2382 10.9778 -61.55%
2005 37.7835 59.9880 59.9880 28.5543 28.5543 -52.96%
2004 51.7600 68.7463 73.0654 28.3143 60.7079 -10.76%
2003 66.5418 64.1872 94.7810 42.7714 68.0264 10.74%
2002 65.3403 92.9214 100.9598 41.1578 61.4277 -37.56%
2001 95.8749 66.3467 120.5759 64.4871 98.3803 48.28%
2000 117.9615 277.4445 315.7169 63.7672 66.3467 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.713B $0.150B
Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's product line includes Oncophage vaccine, a patient-specific therapeutic cancer vaccine. The Company is also developing Prophage, patient-specific therapeutic cancer vaccine; QS-21, vaccine adjuvant; and HerpV, a polyvalent off-the-shelf therapeutic heat shock protein-based vaccine for treatment of genital herpes which are all in the clinical testing stages. Agenus Inc. is headquartered in Lexington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $140.490B 10.02
Amgen (AMGN) United States $130.796B 13.67
CSL (CSLLY) Australia $103.933B 0.00
Gilead Sciences (GILD) United States $76.001B 10.10
Vertex Pharmaceuticals (VRTX) United States $55.120B 25.63
Regeneron Pharmaceuticals (REGN) United States $54.923B 19.48
Illumina (ILMN) United States $43.654B 60.04
Biogen (BIIB) United States $37.549B 6.67
Moderna (MRNA) United States $36.710B 0.00
Seagen (SGEN) United States $31.440B 83.03
Alexion Pharmaceuticals (ALXN) United States $26.710B 10.64
BeiGene (BGNE) Cayman Islands $25.597B 0.00
Genmab (GMAB) Denmark $23.665B 28.01
Genmab (GNMSF) Denmark $22.484B 5.18
BioNTech SE (BNTX) Germany $21.479B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
Incyte (INCY) United States $17.890B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.776B 67.41
Exact Sciences (EXAS) United States $17.025B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.690B 22.43
Alnylam Pharmaceuticals (ALNY) United States $14.384B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.638B 90.52
ARGENX SE-ADR (ARGX) Netherlands $12.417B 0.00
Bio-Techne Corp (TECH) United States $11.670B 74.63
Mirati Therapeutics (MRTX) United States $11.407B 0.00
Guardant Health (GH) United States $10.848B 0.00
QIAGEN (QGEN) Netherlands $10.766B 24.24
Sarepta Therapeutics (SRPT) United States $10.607B 0.00
Repligen (RGEN) United States $9.855B 139.77
ACADIA Pharmaceuticals (ACAD) United States $8.523B 0.00
Galapagos (GLPG) Belgium $8.062B 0.00
Ascendis Pharma (ASND) Denmark $7.990B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.718B 0.00
Denali Therapeutics (DNLI) United States $7.405B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.887B 0.00
Acceleron Pharma (XLRN) United States $6.683B 0.00
Adaptive Biotechnologies (ADPT) United States $6.225B 0.00
Exelixis (EXEL) United States $5.895B 39.58
Amicus Therapeutics (FOLD) United States $5.660B 0.00
Reata Pharmaceuticals (RETA) United States $5.550B 0.00
Novavax (NVAX) United States $5.500B 0.00
Blueprint Medicines (BPMC) United States $5.390B 17.84
SWEDISH ORP BIO (BIOVF) Sweden $5.385B 14.71
Halozyme Therapeutics (HALO) United States $5.214B 241.06
Twist Bioscience (TWST) United States $5.114B 0.00
NeoGenomics (NEO) United States $4.744B 1424.33
China Biologic Products (CBPO) China $4.664B 27.69
Fate Therapeutics (FATE) United States $4.337B 0.00
Emergent Biosolutions (EBS) United States $4.270B 14.01
Insmed (INSM) United States $4.047B 0.00
Arena Pharmaceuticals (ARNA) United States $3.826B 0.00
Vir Biotechnology (VIR) United States $3.659B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.643B 0.00
Legend Biotech (LEGN) United States $3.509B 0.00
MorphoSys AG (MOR) Germany $3.473B 125.71
Eidos Therapeutics (EIDX) United States $3.105B 0.00
Bluebird Bio (BLUE) United States $2.931B 0.00
Seres Therapeutics (MCRB) United States $2.925B 0.00
Alkermes (ALKS) Ireland $2.892B 28.39
Global Blood Therapeutics (GBT) United States $2.686B 0.00
I-Mab (IMAB) China $2.298B 0.00
Beam Therapeutics (BEAM) United States $2.291B 0.00
Intra-Cellular Therapies (ITCI) United States $2.082B 0.00
UniQure (QURE) Netherlands $2.054B 0.00
PHARMA MAR SA (PHMMF) Spain $2.028B 0.00
Sorrento Therapeutics (SRNE) United States $2.011B 0.00
Viela Bio (VIE) United States $1.914B 0.00
Intellia Therapeutics (NTLA) United States $1.906B 0.00
Zymeworks (ZYME) Canada $1.902B 0.00
Inovio Pharmaceuticals (INO) United States $1.867B 0.00
Amarin (AMRN) Ireland $1.775B 0.00
Editas Medicine (EDIT) United States $1.747B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.713B 0.00
Revance Therapeutics (RVNC) United States $1.624B 0.00
Mersana Therapeutics (MRSN) United States $1.608B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
NGM Biopharmaceuticals (NGM) United States $1.605B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.594B 0.00
Arcus Biosciences (RCUS) United States $1.578B 0.00
Sangamo Therapeutics (SGMO) United States $1.460B 0.00
Alcobra (ARCT) United States $1.454B 0.00
Zealand Pharma (ZEAL) Denmark $1.434B 0.00
Mesoblast (MESO) Australia $1.383B 0.00
REGENXBIO (RGNX) United States $1.368B 0.00
Scholar Rock Holding (SRRK) United States $1.346B 0.00
Ligand Pharmaceuticals (LGND) United States $1.311B 33.97
Athenex (ATNX) United States $1.303B 0.00
Myriad Genetics (MYGN) United States $1.293B 0.00
Coherus BioSciences (CHRS) United States $1.291B 8.53
Zealand Pharma (ZLDPF) Denmark $1.289B 0.00
Adverum Biotechnologies (ADVM) United States $1.236B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.229B 0.00
Heska (HSKA) United States $1.167B 0.00
Epizyme (EPZM) United States $1.150B 0.00
Precigen (PGEN) United States $1.139B 0.00
Cytokineticsorporated (CYTK) United States $1.121B 0.00
Vericel (VCEL) United States $1.074B 0.00
Northwest Biotherapeutics (NWBO) United States $1.050B 0.00
Genetron Holdings (GTH) China $1.025B 0.00
Alector (ALEC) United States $0.979B 0.00
Codexis (CDXS) United States $0.976B 0.00
Pliant Therapeutics (PLRX) United States $0.971B 0.00
Arvinas (ARVN) United States $0.947B 0.00
Cellectis S.A (CLLS) France $0.939B 0.00
NantKwest (NK) United States $0.923B 0.00
Castle Biosciences (CSTL) United States $0.921B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.911B 0.00
Morphic Holding (MORF) United States $0.908B 0.00
Compugen (CGEN) Israel $0.883B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.880B 0.00
Protagonist Therapeutics (PTGX) United States $0.823B 0.00
Frequency Therapeutics (FREQ) United States $0.815B 0.00
Cara Therapeutics (CARA) United States $0.794B 0.00
Celldex Therapeutics (CLDX) United States $0.791B 0.00
MiMedx (MDXG) United States $0.754B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 17.14
AnaptysBio (ANAB) United States $0.718B 0.00
Five Prime Therapeutics (FPRX) United States $0.691B 0.00
Sutro Biopharma (STRO) United States $0.688B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.682B 34.64
Kadmon Holdings (KDMN) United States $0.669B 0.00
Albireo Pharma (ALBO) United States $0.665B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.663B 0.00
MannKind (MNKD) United States $0.642B 0.00
VBI Vaccines (VBIV) United States $0.641B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Adaptimmune Therapeutics (ADAP) United Kingdom $0.614B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.598B 0.00
Cardiff Oncology (CRDF) United States $0.589B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.587B 0.00
Geron (GERN) United States $0.571B 0.00
Anika Therapeutics (ANIK) United States $0.519B 70.27
Aquinox Pharmaceuticals (NLTX) United States $0.512B 0.00
Forte Biosciences (FBRX) United States $0.508B 0.00
Precision BioSciences (DTIL) United States $0.508B 0.00
IVERIC Bio (ISEE) United States $0.507B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.505B 0.00
Avid Bioservices (CDMO) United States $0.504B 0.00
MeiraGTx Holdings (MGTX) United States $0.496B 0.00
Dynavax Technologies (DVAX) United States $0.490B 0.00
Prothena (PRTA) Ireland $0.471B 0.00
Amryt Pharma (AMYT) United Kingdom $0.454B 0.00
UROGEN PHARMA (URGN) United States $0.452B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.449B 0.00
Cel-Sci (CVM) United States $0.439B 0.00
Merus (MRUS) Netherlands $0.436B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.432B 0.00
WAVE Life Sciences (WVE) Singapore $0.428B 0.00
Kala Pharmaceuticals (KALA) United States $0.426B 0.00
BioDelivery Sciences (BDSI) United States $0.415B 19.52
Innate Pharma S.A (IPHA) France $0.402B 0.00
Spero Therapeutics (SPRO) United States $0.402B 0.00
Puma Biotechnology (PBYI) United States $0.400B 0.00
Starpharma Holdings (SPHRY) Australia $0.397B 0.00
Trevena (TRVN) United States $0.385B 0.00
Cue Biopharma (CUE) United States $0.385B 0.00
AC Immune SA (ACIU) Switzerland $0.380B 0.00
Clovis Oncology (CLVS) United States $0.379B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.369B 0.00
Affimed (AFMD) Germany $0.368B 0.00
Syros Pharmaceuticals (SYRS) United States $0.361B 0.00
Cellular Biomedicine (CBMG) United States $0.357B 0.00
XOMA (XOMA) United States $0.355B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.347B 0.00
Selecta Biosciences (SELB) United States $0.346B 0.00
ANI Pharmaceuticals (ANIP) United States $0.344B 8.76
CytomX Therapeutics (CTMX) United States $0.343B 0.00
Athersys (ATHX) United States $0.306B 0.00
ChromaDex (CDXC) United States $0.303B 0.00
Kamada (KMDA) Israel $0.297B 13.92
IBio (IBIO) United States $0.295B 0.00
Arbutus Biopharma (ABUS) United States $0.284B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.281B 0.00
NextCure (NXTC) United States $0.275B 0.00
DBV Technologies S.A (DBVT) France $0.259B 0.00
Fortress Biotech (FBIO) United States $0.259B 0.00
Verastem (VSTM) United States $0.250B 0.00
HOOKIPA Pharma (HOOK) United States $0.238B 0.00
TELA Bio (TELA) United States $0.237B 0.00
Pluristem Therapeutics (PSTI) Israel $0.235B 0.00
CorMedix Inc (CRMD) United States $0.219B 0.00
Aptinyx (APTX) United States $0.201B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.195B 0.00
Bellus Health (BLU) Canada $0.192B 0.00
Aptevo Therapeutics (APVO) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.182B 0.00
Dyadic (DYAI) United States $0.181B 0.00
Eton Pharmaceuticals (ETON) United States $0.178B 0.00
Theratechnologies (THTX) Canada $0.178B 0.00
AquaBounty Technologies (AQB) United States $0.174B 0.00
Strongbridge Biopharma (SBBP) United States $0.173B 0.00
Cerecor (CERC) United States $0.172B 0.00
ADMA Biologics Inc (ADMA) United States $0.170B 0.00
Nicox SA (NICXF) France $0.170B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.169B 0.00
Checkpoint Therapeutics (CKPT) United States $0.168B 0.00
VolitionRX (VNRX) United States $0.166B 0.00
Biofrontera AG (BFRA) Germany $0.163B 0.00
GENFIT S.A (GNFT) France $0.160B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.153B 0.00
Oncobiologics (OTLK) United States $0.153B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.152B 0.00
SESEN BIO, INC (SESN) United States $0.149B 0.00
Kindred Biosciences (KIN) United States $0.148B 0.00
VTv Therapeutics (VTVT) United States $0.138B 0.00
Lumos Pharma (LUMO) United States $0.133B 0.00
Abeona Therapeutics (ABEO) United States $0.132B 0.00
Prometic Life Sciences (LMNL) Canada $0.130B 0.00
Protalix BioTherapeutics (PLX) Israel $0.130B 0.00
Liquidia Technologies (LQDA) United States $0.128B 0.00
Exicure (XCUR) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.127B 0.00
Idera Pharmaceuticals (IDRA) United States $0.127B 0.00
Celyad SA (CYAD) Belgium $0.123B 0.00
Antibe Therapeutics (ATBPF) Canada $0.121B 0.00
TRACON Pharmaceuticals (TCON) United States $0.117B 0.00
Aytu Bioscience (AYTU) United States $0.116B 0.00
Orgenesis (ORGS) United States $0.114B 235.00
Novogen (KZIA) Australia $0.114B 0.00
Cogent Biosciences (COGT) United States $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.110B 0.00
Cidara Therapeutics (CDTX) United States $0.109B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.108B 0.00
Applied Genetic Technologies (AGTC) United States $0.105B 0.00
Gritstone Oncology (GRTS) United States $0.103B 0.00
Cyclerion Therapeutics (CYCN) United States $0.103B 0.00
Palatin Technologies (PTN) United States $0.100B 0.00
AIT Therapeutics (XAIR) United States $0.095B 0.00
Enzo Biochem (ENZ) United States $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.091B 0.00
Clearside Biomedical (CLSD) United States $0.086B 0.00
Ecology Coatings (ABVC) United States $0.083B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.078B 0.00
Bionano Genomics (BNGO) United States $0.077B 0.00
Stealth BioTherapeutics (MITO) United States $0.077B 37.00
Curis (CRIS) United States $0.076B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Synlogic (SYBX) United States $0.072B 0.00
Soligenix (SNGX) United States $0.072B 0.00
Evogene (EVGN) Israel $0.072B 0.00
MiRagen Therapeutics (MGEN) United States $0.072B 0.00
Adocia (ADOCY) France $0.067B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.061B 0.00
Cocrystal Pharma (COCP) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.060B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Emmaus Life Sciences (EMMA) United States $0.053B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Happiness Biotech Group (HAPP) China $0.049B 0.00
Edesa Biotech (EDSA) Canada $0.047B 0.00
Vaccinex (VCNX) United States $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
Seelos Therapeutics (SEEL) United States $0.043B 0.00
IMMURON (IMRN) Australia $0.042B 0.00
Genetic Technologies (GENE) Australia $0.041B 0.00
Cleveland BioLabs (CBLI) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.036B 0.00
Pulmatrix (PULM) United States $0.036B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Chanticleer Holdings (SONN) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
Titan Pharmaceuticals (TTNP) United States $0.034B 0.00
OvaScience (MLND) United States $0.032B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.028B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Prana Biotechnology (ATHE) Australia $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
Celsion (CLSN) United States $0.019B 0.00
Spherix (AIKI) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.011B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00